Imatinib mesylate for gastrointestinal stromal tumours (GISTs)

  • Withdrawn
  • Protocol
  • Intervention


Karin L Dearness, Department of Medicine, McMaster University, 1200 Main Street West, HSC 3N51C, Hamilton, Ontario, L8N 3Z5, Canada.

Reason for withdrawal from publication

The protocol was withdrawn in August 2012 due to lack of progress. The protocol had previously been withdrawn in April 2011 and registered by a new review team.